SARS-CoV-2 re-infection rate in Iranian COVID-19 cases within one-year follow-up-Reference-Cited by-同舟云学术

SARS-CoV-2 re-infection rate in Iranian COVID-19 cases within one-year follow-up

Published:2021-12 Issue: Volume:161 Page:105296
ISSN:0882-4010
Container-title:Microbial Pathogenesis
language:en
Short-container-title:Microbial Pathogenesis

Author:

Salehi-Vaziri Mostafa,Pouriayevali Mohammad Hassan,Fotouhi Fatemeh,Jalali Tahmineh,Banifazl Mohammad,Farahmand Behrokh,Sadat Larijani Mona,Ahmadi Zahra,Fereydouni Zahra,Tavakoli Mahsa,Karami Afsaneh,Azad-Manjiri Sanam,Yektay Sanati Parastoo,Dahmardeh Sarah,Nemati Amir Hesam,Sajadi Marzyie,Kashanian Setareh,Ramezani Amitis^ORCID

Funder

Pasteur Institute of Iran

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology

Reference18 articles.

1. Iwasaki A. What Re-infection S Mean for COVID-19. The Lancet Infectious Diseases..

2. Tillett RL, Sevinsky JR, Hartley PD, et al. Genomic Evidence for Re-infection with SARS-CoV-2: a Case Study. The Lancet Infectious Diseases..

3. Covid-19: Hong Kong scientists report first confirmed case of re-infection;Parry;BMJ,2020

4. Re-infection with SARS-CoV-2: Implementation of a Surveillance Case Definition within the EU/EEA;Control ECfDPa,2021

5. SARS-CoV-2, a virus with many faces: a series of cases with prolonged persistence of COVID-19 symptoms;Sofian;Wien Med. Wochenschr.,2020

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and efficiency of COVID-19 vaccine in North Africa;Human Vaccines & Immunotherapeutics;2024-02-02

2. Psychometric properties of the COVID-19 Yorkshire Rehabilitation Scale: Post-Covid-19 syndrome in Iranian elderly population;BMC Infectious Diseases;2024-01-11

3. Epidemiological surveillance of respiratory viral infections in SARS-CoV-2-negative samples during COVID-19 pandemic in Iran;Virology Journal;2023-12-13

4. Incidence and outcome of SARS-CoV-2 reinfection in the pre-Omicron era: A global systematic review and meta-analysis;Journal of Global Health;2023-11-24

5. Immunogenicity and safety of heterologous boost immunization with PastoCovac Plus against COVID-19 in ChAdOx1-S or BBIBP-CorV primed individuals;PLOS Pathogens;2023-11-01